Literature DB >> 11602600

Prolactin negatively regulates caveolin-1 gene expression in the mammary gland during lactation, via a Ras-dependent mechanism.

D S Park1, H Lee, C Riedel, J Hulit, P E Scherer, R G Pestell, M P Lisanti.   

Abstract

Caveolin-1 is a 22-kDa integral membrane protein that has been suggested to function as a negative regulator of mitogen-stimulated proliferation in a variety of cell types, including mammary epithelial cells. Because much of our insight into caveolin-1 function has come from the study of human breast tumor-derived cell lines in culture, the normal physiological regulators of caveolin-1 expression in the mammary gland remain unknown. Here, we examine caveolin-1 expression in mice at different stages of mammary gland development. We show that caveolin-1 expression is significantly down-regulated during late pregnancy and lactation. Upon weaning, mammary gland expression of caveolin-1 rapidly returns to non-pregnant "steady-state" levels. Injection of virgin mice with a battery of hormones normally up-regulated during lactation demonstrates that prolactin is the main mediator of caveolin-1 down-regulation. Virtually identical results were obtained with human mammary epithelial cells (hTERT-HME1) in culture. In addition, we demonstrate that prolactin-mediated down-regulation of caveolin-1 expression occurs at the level of transcriptional control and via a Ras-dependent mechanism. Interestingly, in the mammary gland, both mammary epithelial cells and the surrounding mammary adipocytes show prolactin-mediated down-regulation of caveolin-1. This hormone-dependent regulation of caveolin-1 expression is specific to the mammary fat pad. Finally, we employed HC11 cells, a well-established model of mammary epithelial cell differentiation, to study the possible functional effects of caveolin-1 expression. In the presence of lactogenic hormones, recombinant expression of caveolin-1 in HC11 cells dramatically suppresses the induction of the promoter activity and the synthesis of beta-casein, an established reporter of lactogenic differentiation and milk production. These findings may explain why caveolin-1 levels are normally down-regulated during lactation. This report is the first demonstration that caveolin-1 levels are down-regulated during a normal physiological event in vivo, i.e. lactation, because previous reports have only documented that down-regulation of caveolin-1 occurs during cell transformation and tumorigenesis.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11602600     DOI: 10.1074/jbc.M108210200

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  14 in total

Review 1.  Alveolar and lactogenic differentiation.

Authors:  Cathrin Brisken; Renuga Devi Rajaram
Journal:  J Mammary Gland Biol Neoplasia       Date:  2006-10       Impact factor: 2.673

2.  Caveolin-1-deficient mice show accelerated mammary gland development during pregnancy, premature lactation, and hyperactivation of the Jak-2/STAT5a signaling cascade.

Authors:  David S Park; Hyangkyu Lee; Philippe G Frank; Babak Razani; Andrew V Nguyen; Albert F Parlow; Robert G Russell; James Hulit; Richard G Pestell; Michael P Lisanti
Journal:  Mol Biol Cell       Date:  2002-10       Impact factor: 4.138

Review 3.  Triple negative breast cancer cell lines: one tool in the search for better treatment of triple negative breast cancer.

Authors:  Kathryn J Chavez; Sireesha V Garimella; Stanley Lipkowitz
Journal:  Breast Dis       Date:  2010

4.  Stromal and epithelial caveolin-1 both confer a protective effect against mammary hyperplasia and tumorigenesis: Caveolin-1 antagonizes cyclin D1 function in mammary epithelial cells.

Authors:  Terence M Williams; Federica Sotgia; Hyangkyu Lee; Ghada Hassan; Dolores Di Vizio; Gloria Bonuccelli; Franco Capozza; Isabelle Mercier; Hallgeir Rui; Richard G Pestell; Michael P Lisanti
Journal:  Am J Pathol       Date:  2006-11       Impact factor: 4.307

5.  Regulation of Cripto-1 signaling and biological activity by caveolin-1 in mammary epithelial cells.

Authors:  Caterina Bianco; Luigi Strizzi; Mario Mancino; Kazuhide Watanabe; Monica Gonzales; Shin Hamada; Ahmed Raafat; Lawson Sahlah; Cindy Chang; Federica Sotgia; Nicola Normanno; Michael Lisanti; David S Salomon
Journal:  Am J Pathol       Date:  2008-01-17       Impact factor: 4.307

6.  Direct control of caveolin-1 expression by FOXO transcription factors.

Authors:  A Pieter J van den Heuvel; Almut Schulze; Boudewijn M T Burgering
Journal:  Biochem J       Date:  2005-02-01       Impact factor: 3.857

7.  Caveolin-1 mutations (P132L and null) and the pathogenesis of breast cancer: caveolin-1 (P132L) behaves in a dominant-negative manner and caveolin-1 (-/-) null mice show mammary epithelial cell hyperplasia.

Authors:  Hyangkyu Lee; David S Park; Babak Razani; Robert G Russell; Richard G Pestell; Michael P Lisanti
Journal:  Am J Pathol       Date:  2002-10       Impact factor: 4.307

8.  An Rb family-independent E2F3 transcription factor variant impairs STAT5 signaling and mammary gland remodeling during pregnancy in mice.

Authors:  Yang Liao; Wei Du
Journal:  J Biol Chem       Date:  2018-01-12       Impact factor: 5.157

Review 9.  Integrins in mammary-stem-cell biology and breast-cancer progression--a role in cancer stem cells?

Authors:  Stephanie M Pontier; William J Muller
Journal:  J Cell Sci       Date:  2009-01-15       Impact factor: 5.285

Review 10.  Dystroglycan: emerging roles in mammary gland function.

Authors:  M Lynn Weir; John Muschler
Journal:  J Mammary Gland Biol Neoplasia       Date:  2003-10       Impact factor: 2.673

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.